Latest papers

Treatment of clozapine- and molindone-induced agranulocytosis with granulocyte colony-stimulating factor.

Molindone and weight loss.

The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus. Case reports.

Neuroleptic malignant syndrome possibly caused by molindone hydrochloride.

Neuroleptics and learning: effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure.

Neuroleptic-induced painful legs and moving toes syndrome: successful treatment with clonazepam and baclofen.

Effect of typical and atypical neuroleptic treatment on protachykinin mRNA levels in the striatum of the rat.

Polydipsia and hyponatremia induced by multiple neuroleptics but not molindone.

A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia.

Tardive dyskinesia associated with molindone treatment.

Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors.

Relation of serum molindone levels to serum prolactin levels and antipsychotic response.

Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome.

Molindone hydrochloride: a review of laboratory and clinical findings.

Molindone: effects in pigeons responding under conditional discrimination tasks.

Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.

D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.

Potentiation of dopamine receptor-mediated responses by B-HT 920 in mice.

Rhabdomyolysis and molindone.

Rhabdomyolysis and acute renal failure.